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Abstract 
Background 
Vitamin D concentrations during pregnancy are measured to diagnose states of insufficiency 
or deficiency. The aim of this study is to apply accurate assays of vitamin D forms [single- 
hydroxylated [25(OH)D2, 25(OH)D3], double-hydroxylated [1α,25(OH)2D2, 1α,25(OH)2D3], 
epimers [3-epi-25(OH)D2, 3-epi-25(OH)D3] in mothers (serum) and neonates (umbilical 
cord) to i) explore maternal and neonatal vitamin D biodynamics and ii) to identify maternal 
predictors of neonatal vitamin D concentrations. 
Methods 
All vitamin D forms were quantified in 60 mother- neonate paired samples by a novel liquid 
chromatography -mass spectrometry (LC-MS/MS) assay. Maternal characteristics [age, 
ultraviolet B exposure, dietary vitamin D intake, calcium, phosphorus and parathyroid 
hormone] were recorded. Hierarchical linear regression was used to predict neonatal 
25(OH)D concentrations. 
Results 
Mothers had similar concentrations of 25(OH)D2 and 25(OH)D3 forms compared to neonates 
(17.9 ± 13.2 vs. 15.9 ± 13.6 ng/mL, p = 0.289) with a ratio of 1:3. The epimer concentrations, 
which contribute approximately 25% to the total vitamin D levels, were similar in mothers 
and neonates (4.8 ± 7.8 vs. 4.5 ± 4.7 ng/mL, p = 0.556). No correlation was observed in 
mothers between the levels of the circulating form (25OHD3) and its active form. Neonatal 
25(OH)D2 was best predicted by maternal characteristics, whereas 25(OH)D3 was strongly 
associated to maternal vitamin D forms (R2 = 0.253 vs. 0.076 and R2 = 0.109 vs. 0.478, 
respectively). Maternal characteristics explained 12.2% of the neonatal 25(OH)D, maternal 
25(OH)D concentrations explained 32.1%, while epimers contributed an additional 11.9%. 
Conclusions 
By applying anovel highly specific vitamin D assay, the present study is the first to quantify 
3-epi-25(OH)D concentrations in mother - newborn pairs. This accurate assay highlights a 
considerable proportion of vitamin D exists as epimers and a lack of correlation between the 
circulating and active forms. These results highlight the need for accurate measurements to 
appraise vitamin D status. Maternal characteristics and circulating forms of vitamin D, along 
with their epimers explain 56% of neonate vitamin D concentrations. The roles of active and 
epimer forms in the maternal - neonatal vitamin D relationship warrant further investigation. 
Keywords 
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Introduction 
Vitamin D insufficiency and deficiency has been associated with a wide spectrum of diseases, 
ranging from neurological disorders to chronic inflammatory conditions [1]. The resurgence 
of rickets in some Western countries highlights the potential risks of not gaining sufficient 
vitamin D through diet, supplementation or exposure to sunlight [2,3]. Vitamin D deficiency 
is frequently defined as serum concentrations less than 20 ng/mL with concentrations 
between 21–29 ng/mL treated as insufficiency and greater than 30 ng/mL as sufficient [4-7]. 
Recent studies attest to widespread insufficiency of vitamin D in many Western nations, 
namely the UK, USA and other European countries, including Greece [5,6,8]. Vitamin D 
deficiency during pregnancy has been associated with maternal morbidity, including 
gestational diabetes [9] and an increased rate of caesarean section [10]. Likewise, for the 
neonate, there is a putative association with being small-for-gestational age (SGA) [11]. 
Finally, as far as children are concerned, impaired neurocognitive development [12] and 
skeletal problems, such as reduced bone mineral content [13] have been reported. 
A recent report details the importance of maternal circulating vitamin D concentrations in 
determining neonatal circulating vitamin D [14]. The authors compared the contributions of 
genetic factors to maternal vitamin D levels and found that 19% of neonatal circulating 
vitamin D levels are predicted by the latter with genetics having little influence. The recent 
report of a lack of significant relationship between circulating 25(OH)D and the highly active 
1,25-(OH)2D concentrations in a meta-analysis of mother-neonate studies suggest that 
measurement of vitamin D concentrations should go beyond the routinely measured 
25(OH)D forms [15]. Many studies have relied on questionable assays to assess 
concentrations of the various forms of vitamin D [16,17]. Given the complexities involved in 
rigorous assessment of vitamin D analogues, a novel assay was recently introduced to 
differentiate and quantify the circulating precursors and active forms from biologically 
inactive epimers [18,19]. It is envisaged that the role of vitamin D in disease prevention and 
treatment can be further elucidated with the accurate measurement of all forms of vitamin D, 
including epimers. 
The primary aim of this study was to determine serum (mothers) and umbilical cord 
(neonates) concentrations of all vitamin D forms [single-hydroxylated [25(OH)D2, 
25(OH)D3], double-hydroxylated [1α,25(OH) 2D2, 1α,25(OH) 2D3], epimers [3-epi-
25(OH)D2, 3-epi-25(OH)D3]], in a Northern Greece cohort of pregnant women at term and 
their neonates, by applying a novel highly specific and accurate assay. A secondary aim was 
to predict neonatal vitamin D concentrations by means of maternal parameters. 
Subjects and methods 
Subjects 
The study was conducted from January 2011 until December 2011. Pregnant women were 
recruited from the Maternity Unit of the First Department of Obstetrics and Gynaecology, 
Aristotle University, Thessaloniki, Greece. Inclusion criterion was full-term pregnancy (37th 
-42th gestational week). Maternal exclusion criteria were primary hyperparathyroidism, 
secondary osteoporosis, liver disease, hyperthyroidism, nephrotic syndrome, inflammatory 
bowel disease, rheumatoid arthritis, osteomalacia, morbid obesity, diabetes in pregnancy, age 
< 18 year and use of medications affecting calcium (Ca) or vitamin D status. Neonatal 
exclusion criteria were being small-for-gestational age (SGA) and presence of severe 
congenital anomaly. Informed consent was obtained from all mothers. The protocol received 
approval from the Bioethics Committee of Aristotle University of Thessaloniki, Greece. 
Demographics and diet 
At enrolment, demographic and social characteristics were recorded. Ca and vitamin D 
dietary intake during the last month of pregnancy were assessed through a validated, semi- 
quantitative, food frequency questionnaire that includes 150 foods and beverages [20]. For 
each dietary item, participants were asked to report their frequency of consumption and 
portion size. From these data, calculations were made for estimations of consumed quantities 
(in g per day) and total energy intake (in kcal per day), on the basis of a food composition 
database, modified to accommodate the particularities of the Greek diet [21]. 
Biochemical and hormonal assays 
Blood samples were obtained from mothers by antecubital venipuncture 30–60 minutes 
before delivery. Umbilical cord blood was collected immediately after clamping, from the 
umbilical vein. Serum and umbilical cord specimens were stored at −20°C prior to analysis 
for the following parameters: Ca, phosphorus (P), parathyroid hormone (PTH), vitamin D2, 
vitamin D3, 25(OH)D2, 25(OH)D3, 1α,25(OH) 2D2, 1α,25(OH) 2D3, 3-epi-25(OH)D2 and 3-
epi-25(OH)D3. Serum Ca and P determinations were performed using the Cobas INTEGRA 
clinical chemistry system (D-68298; Roche Diagnostics, Mannheim, Germany). The inter- 
and intra-assay coefficients of variation (CVs) were 0.99% and 3.5% for Ca, and 1.3% and 
2.5% for P, respectively. PTH determinations were performed using the 
electrochemiluminescence immunoassay ECLIA (Roche Diagnostics GmbA, Mannheim, 
Germany). Reference range for PTH was 15–65 pg/mL, functional sensitivity 6.0 pg/mL, 
within-run precision 0.6 - 2.8% and total precision 1.6 - 3.4%. Using the novel assay, a total 
of eight forms of vitamin D were quantified by liquid chromatography tandem mass 
spectrometry (LC-MS/MS) with lower limits of quantification (LLOQ) as follows: vitamin 
D2 (0.5 ng/mL), vitamin D3 (0.5 ng/mL), 25(OH)D2 (0.5 ng/mL), 25(OH)D3 (0.5 ng/mL), 
1α,25(OH)2D2 (0.015 ng/mL), 1α,25(OH)2D3 (0.015 ng/mL) , 3-epi-25(OH)D2 (0.01 ng/mL) 
and 3-epi-25(OH)D3 (0.015 ng/mL). Briefly, the assay involves a chiral column in tandem 
with a rapid resolution microbore column along with liquid-liquid extraction. The method is 
fully validated using quality controls at four different concentration levels (QCL, QCM, 
QCH, LLOQ). Quality controls were calculated after chromatographically separating the 
epimers, isobars and other analogues. The same concentrations were recovered from spiked 
quality controls prepared in house. The accuracy of the assay was also double checked using 
DEQAS and Chromsystem quality controls. Full method validation parameters have been 
reported previously [18,19]. Maternal vitamin D deficiency was defined as serum 
concentrations ≤ 20 ng/mL, insufficiency as 21–29 ng/mL and sufficiency as ≥ 30 ng/mL. 
UVB measurements 
Ultraviolet B (UVB) radiation includes wavelengths from 280 to 320 nm. UVB data for the 
broad geographical region of Thessaloniki, Greece were collected from the Section of 
Applied and Environmental Physics, Aristotle University of Thessaloniki. Daily integral of 
effective UVB radiation from sunrise to sunset (from 09:00 to 16:00) was used as the most 
representative parameter for UVB exposure. These hours were selected as they represent the 
beginning and the end of the working time for the majority of the population. Individual 
sunlight exposure was recorded for each participant during that period. Finally, mean UVB 
exposure during the previous 45 days (daily integral) before blood sample collection 
(estimated mean half-life of vitamin D) was calculated for each participant. 
Statistical analysis 
The dependent variables (DV) were the concentrations of circulating vitamin D2 and D3 in 
neonates. Adjusted body mass index (BMI) was calculated by adjusting the pre-delivery 
weight with the average expected weight gain based on the mother’s pre-pregnancy BMI. In 
cases below the limit of quantification (BLQ), a conservative zero value was imputed. Owing 
to large within group variances, vitamin D concentrations between mothers and neonates 
were compared using Wilcoxon Signed Rank test. ANOVA was used to compare the 
circulating vitamin D concentrations in neonates of mothers with deficient, insufficient and 
sufficient vitamin D status. To determine the explained variances by the independent 
variables (IV) in predicting the DV (neonatal serum vitamin D2 and D3, separately), two 
hierarchical linear regression analyses were used. In both models, in order to control for 
random differences between mothers (e.g. maternal age, number of previous live birth, UVB 
exposure and vitamin D), these variables were entered in the first block, followed by serum 
concentrations of 25OHD2 and D3, along with their corresponding epimers, individually. 
Meeting assumptions for the regression models were defined as follows: Durbin-Watson 
statistics (d) between 1.5 and 2.5 for auto-correlation of residuals and Variance Inflating 
Factor (VIF) < 5 for multi-colinearity, along with satisfactory normal P-P plot of regressions 
standardized residual. The level of significance was set as p < 0.05. All statistical analyses 
were conducted in SPSS v19 (SPSS Inc, Chicago, Ill). 
Results 
The sample consisted of 60 pairs of Caucasian mothers and their neonates. Mean maternal 
age was 32.8 ± 5.2 years, 40% with previous live birth (31.7% primiparous and 8.3% 
multiparous). The mean pre-conception BMI was 22.2 ± 3.3 kg/m2 (range 16.1 - 31.6), 
adjusted BMI was 22.4 ± 4.3 kg/m2 (range 13.5 - 35.5). Thirty-six women were on Ca 
supplementation (range 250 – 1000 mg per day, with 32 on 500 mg per day) and none were 
on vitamin D supplementation. Of the 60 neonates, 67% were female. PTH, Ca, P 
concentrations of mothers and neonates, along with the estimated daily average intake of Ca 
and vitamin D, and UVB exposure are presented in Table 1. 
Table 1 Measures of PTH, Ca, P concentrations of mothers and neonates, and daily 
average intake of Ca, vitamin D 
 Mother Neonates 
 Range Mean ± SD Range Mean ± SD 
Vitamin D a intake (µg/day) 0.35-5781.00 421.97 ± 1206.130 - - 
Ca intake a (mg/day) 111.0-1935.40 786.10 ± 360.240 - - 
UVB (wh/m2) 0.01-0.36 0.20 ± 0.11 - - 
PTH (mg/dL)b 19.00-85.40 36.91 ± 15.15 1.20-17.90 6.99 ± 2.78 
Ca (mg/dL)c 4.20-9.60 8.56 ± 0.75 8.90-11.80 10.32 ± 0.62 
P (pg/mL)c 1.40-5.00 3.58 ± 0.63 4.30-7.10 5.73 ± 0.58 
a
 mother n = 58. 
b
 mother n = 59, neonate n = 57. 
c
 mother n = 60, neonate n = 57. 
Maternal and neonatal vitamin 25(OH)D concentrations 
Mothers had slightly, but not statistically significantly, higher concentrations of circulating 
vitamin D [25(OH)D2 and 25(OH)D3] compared to neonates (17. 9 ± 13.2 vs. 15.9 ± 13.6 
ng/mL, W = 771.0, p = 0.289) (Figure 1). The proportions of the mothers with sufficient, 
insufficient and deficient 25(OH)D concentrations are shown in Figure 2A. The frequency 
distribution revealed 40 women below 20 ng/mL, with a further 11 between 21–29 ng/mL, 
leaving a minority in the sufficient range. Notably, whilst the pattern of neonatal 25(OH)D 
concentration roughly followed the same of the mothers in the deficient and insufficient 
mother groups, it varied widely resembling uniform distribution in the group of mothers with 
sufficient vitamin D status. Although thresholds for neonatal serum vitamin D sufficiency are 
yet to be established, the frequency distribution of neonatal 25(OH)D concentrations (Figure 
2B), followed the pattern of the maternal circulating levels, with the majority of the values 
being concentrated at the low end of the spectrum. The mean neonatal 25(OH)D 
concentrations in the three maternal groups were significantly different [12.5 ± 8.7 vs. 19.2 ± 
9.1 vs. 26.6 ± 26.3 ng/mL, F(2,59) = 4.914, p =0.011] for neonates of mothers in the 
deficient, insufficient and sufficient group, respectively. This overall result was due to a 
difference between the deficient and sufficient groups (p =0.012), but not due to other 
comparisons (deficient vs. insufficient, p = 0.279 and insufficient vs. sufficient, p = 0.413). 
Figure 1 Mean concentration of (A) maternal and (B) neonatal vitamin D forms. 1: 
25(OH)D2, 2: 25(OH)D3, 3: 3-epi-25(OH)D2, 4: 3-epi-25(OH)D3, 5: 1α,25(OH)2D3. Bars 
represent within-group standard deviations. Mean values for each analyte are presented in 
Additional file 1. 
Figure 2 Frequency distribution of (A) maternal and (B) neonatal 25(OH)D 
concentrations. 
Proportions of vitamin D forms 
Mean concentrations of vitamin D forms in mothers and neonates are illustrated in Figure 1. 
As far as the 1α,25(OH)2D2 and 1α,25(OH)2D3 forms are concerned, only 1α,25(OH)2D3 was 
measured in mothers, at a very low concentration (0.06 ± 0.06 ng/mL). The 1α,25(OH)2D2 
form was below the limit of quantitation. In line with previous reports [15], no significant 
relationship was observed between maternal circulating forms [25(OH)D3] and the highly 
active 1,25(OH)2D3 concentrations (r = −0.011, p = 0.931).The epimer concentrations (Figure 
1) were similar in mothers and neonates (4.8 ± 7.8 vs. 4.5 ± 4.7 ng/mL, W = 1015.0, p = 
0.462). Notably, 24.7% and 22.2% of the measured vitamin D forms were for inactive epimer 
forms for mothers and neonates, respectively. The 25(OH)D3 concentrations were higher 
compared to 25(OH)D2 levels (75.6 ± 22.2% in mothers and 75.9 ± 23.9% in neonates); thus, 
the ratios of 25(OH)D3: 25(OH)D2 were 3:1, approximately, for both mother and neonates. A 
summary table of means, standard deviations and mean measurement errors for the primary 
forms of vitamins D2 and D3 along with the active forms and their epimers is provided in 
Additional file 1. A positive correlation (r = 0.543, p < 0.001) was detected between maternal 
and neonatal 25(OH)D concentrations, whereas inactive [3-epi-25(OH)D] concentrations 
showed a weaker correlation (r = 0.268, p = 0.038) (Figure 3). The 25(OH)D and inactive [3-
epi-25(OH)D] concentrations were positively correlated in the mothers (r = 0.528, p < 0.001) 
but not in the neonates (r = 0.142, p = 0.414). There was no significant correlation between 
1α,25(OH)2D3 and 3-epi-25(OH)D concentrations. 
Figure 3 Relationship between maternal and neonatal concentrations of (A) 25(OH)D 
[total 25(OH)D2 and 25(OH)D3] and (B) 3-epimers [total 3-epi-25(OH)D2 and 3-epi-
25(OH)D3]. The fitted regression lines are accompanied by 95% confidence intervals. 
Maternal predictors of neonatal vitamin D concentrations 
The hierarchical linear regression models for predicting neonatal 25(OH)D concentrations are 
detailed in Table 2. The correlation matrix (Pearson’s r) is provided in Additional file 2. In 
the majority of analyses, assumptions were met as defined. In the independent models (Table 
2), the neonatal 25(OH)D2 concentrations were best predicted from maternal characteristics 
(R2 = 0.253), whereas 25(OH)D3 was strongly linked to maternal vitamin D forms (R2 = 
0.478). Maternal serum concentrations of PTH, Ca and P together only explained a small 
proportion of the neonatal 25(OH)D2 (R2 = 0.046) and an even smaller part of the 25(OH)D3 
(R2 = 0.013). Neonatal vitamin D concentrations were calculated as the sum of 25(OH)D2 and 
25(OH)D3. Circulating neonatal vitamin D concentrations in newborns followed the pattern 
of predicting 25(OH)D3, with maternal 25(OH)D2 and 25(OH)D3 explaining 32.1% of the 
neonatal vitamin D variance and epimer forms contributing an additional 11.9%. Therefore, 
all four maternal vitamin D forms combined [25(OH)D2, 25(OH)D3, 3-epi-25(OH)D2, 3-epi-
25(OH)D3] explained 44% of the neonatal vitamin D concentrations when controlled for 
other maternal characteristics such as age, UVB exposure, vitamin D and Ca intake and Ca, P 
and PTH concentrations. On the contrary, 1α,25(OH)2D3 did not make a contribution to the 
neonatal vitamin D concentrations. Predicting 25(OH)D in neonates, mother’s age showed 
statistical significance for the coefficients (β = −0.343). For 25(OH)D2, mother’s 25(OH)D2 
concentrations showed statistical significance for the coefficients (β = 0.218) and 3-epi-
25(OH)D3 (β = 0.596). These standardized β values can be used for weighting each 
individual’s measures on the IVs to obtain individual predicted score on the DV, respectively. 
Mother’s age was independent of vitamin D intake (r = −0.093, p = 0.483), negatively 
correlated with UVB exposure (r = −0.304, p = 0.019) and weakly negatively correlated with 
Ca intake (r = −0.244, p = 0.062). 
Table 2 Hierarchical linear regression model for predicting neonatal 25(OH)D 
concentrations 
  DV: Neonatal 25(OHD)2 DV: Neonatal 25(OH)D3 
Step IV (Maternal) R2 ∆R2 SD β R2 ∆R2 SD β 
1 UVB exposure   −0.243   −0.121 
 Age   −0.343 *   −0.227 * 
 Adjusted BMI   −0.172   0.032 
 Vitamin D intake   0.082   0.143 
 Ca intake 0.207 0.207 * 0.222 0.096 0.096 −0.018 
2 Serum PTH   0.043   0.046 
 Serum Ca   −0.267   0.169 
 Serum P 0.253 0.046 −0.011 0.109 0.013 −0.161 
3 25(OH)D2 0.254 0.002 0.040 0.267 0.158 ** 0.271* 
4 25(OH)D3 0.302 0.048 0.272 0.438 0.171 *** 0.218 
5 Epi-25(OH)D2 0.303 0.000 0.124 0.518 0.080 ** −0.091 
6 Epi-25(OH)D3 0.309 0.006 −0.179 0.586 0.068** 0.596 ** 
7 1α,25(OH)2D3 0.329 0.020 −0.147 0.587 0.001 0.032 
* p < 0.05; ** p < 0.01, *** p < 0.001. BMI: body mass index, Ca: calcium, DV: dependent 
variable, IV: independent variable, P: phosphorus, PTH: parathyroid hormone, SD: standard 
deviation, UVB: ultraviolet B. 
Discussion 
Maternal and neonatal vitamin 25(OH) D concentrations 
The potential impact of vitamin D deficiency during pregnancy on maternal and neonatal 
health has attracted much interest in recent years. It has been suggested that maintaining 
adequate maternal stores of vitamin D during pregnancy is of vital importance for both 
mothers and neonates to ensure skeletal and extra-skeletal health. 
The results of this study come mainly from a population of pregnant women with vitamin D 
deficiency or insufficiency. Although the study was not designed for this purpose, a high 
prevalence of maternal vitamin D insufficiency and deficiency was detected, in a sunny 
European area, such as Northern Greece. A similar pattern of distribution between maternal 
and neonatal 25(OH)D concentrations was observed, with 25(OH)D3 being the most 
abundant circulating vitamin D form in both mothers and neonates. These results reflect 
previous reports of widespread vitamin D deficiency and insufficiency in Europe and the 
USA. However, the known cross-reactivity of many assays with the epimer forms suggests 
that levels reported in previous studies are overestimations. Furthermore, the conundrum of a 
mismatch between levels of the usually quantified circulating forms (25OHD) and the active 
form (1,25-(OH)2D) [15] have been confirmed in this study, as no relationship was observed 
between 25(OH)D3 and 1,25(OH)2D3 once epimers have been differentiated. 
At this time, there is no documented benefit in measuring 25(OH)D2 and 25(OH)D3, 
separately; serum total 25(OH)D has been designated as the functional indicator of vitamin D 
status [22]. However, the ability to accurately measure serum concentrations of 25(OH)D2 
and 25(OH)D3 brings new potential to both observational and intervention studies. On a 
physiological basis, it could be hypothesised that maternal vitamin D active forms have an 
impact on the newborn, which, to a great extent, depends on the mother to form its dynamic 
vitamin D equilibrium. Therefore, these findings confirm current concerns regarding the 
maintenance of adequate maternal vitamin D status during pregnancy, since the reflection of 
maternal concentrations of these forms explains 32.1% in neonates. It should be noted that 
data on 25(OH)D2 and 25(OH)D3 concentrations exclude epimer forms; thus, caution should 
be paid when comparing them to other studies [8]. 
Given that vitamin D2 is the only high-dose preparation available in many countries, potential 
differences in the ability of assays to accurately detect 25(OH)D2 and 25(OH)D3 are of 
clinical importance, in cases where supplementation is suggested. Moreover, when 25(OH)D 
results are reported as 25(OH)D2 and 25(OH)D3, vitamin D2 administration does reduce 
serum 25(OH)D3 concentrations [23]. Until the physiologic impact of this reduction, if any, is 
clarified by future studies, a low 25(OH)D3 value in the setting of ergocalciferol 
supplementation does not constitute vitamin D deficiency. LC-MS/MS and the potential of 
accurate measurement of both bioactive forms of vitamin D could offer a valuable tool in 
daily practice, in order to avoid data misinterpretation, especially in conditions like 
pregnancy. 
Proportions of vitamin D forms 
The findings of this study, using a novel assay with the ability not just to exclude but also to 
measure vitamin D epimers demonstrated that epimers comprise approximately 25% of the 
measured vitamin D concentrations in both mothers and neonates, following similar patterns 
of distribution. The presence of both 3-epi-25(OH)D2 and 3-epi-25(OH)D3 forms have been 
previously reported in infants [24]. Our group has demonstrated the presence of 3-epi-
25(OH)D3 form, in a small cohort of healthy adults [18]. These results were further 
confirmed in a larger study, in adults [25]. The present study is the first to quantify 
concentrations of the 3-epi-25(OH)D2 in both mothers and neonates. Large inter-individual 
variances in the epimer content were noted in vitamin D concentrations, ranging between 0% 
and 100% with 63.8% of the mothers and 67.8% of the neonates showing epimer to total 
circulating concentration of 25% or less. Thus, the epimer-adjusted concentration is only 
applicable to conclusions at the aggregated level (i.e. mothers, neonates) and should not be 
used for making judgments at the individual level, unless 3-epi-25(OH)D2 and 3-epi-
25(OH)D3 are clearly separated and excluded from the 25(OH)D measurements. On the other 
hand, based on present results, it becomes evident that 1α, 25(OH)2D2 and 1α,25(OH)2D3 
have minor contributions to the sum of vitamin D measurements in both mothers and infants. 
Based on these findings, it could be hypothesized that assays that do not separate the 3-epi 
forms or have significant cross-reactivity with the epimer will, most likely, report erroneously 
high concentrations for both infants and adults, as 3-epi constitutes a substantial fraction of 
total 25(OH)D. This assay limitation should be considered by clinicians measuring vitamin D 
status in infants and mothers. LC-MS/MS, by measuring vitamin D isoforms separately, 
provides a ‘clear-cut’ view of vitamin D status. By excluding epimer concentrations, it 
appears that the mean vitamin D concentration in term pregnancies is considerably below the 
sufficiency threshold. Although the sample size of the present study was small for drawing 
conclusions, the accurate measurement of active vitamin D metabolites could offer a valuable 
tool in the establishment of a novel, realistic view of vitamin D status during pregnancy. 
Maternal predictors of neonatal vitamin D concentrations 
Based on our primary results, regarding the accurate proportions of vitamin D metabolites in 
maternal circulation, we further investigated if there is an ability to predict neonatal 25(OH)D 
concentrations from maternal parameters. Our analysis showed that, apart from being a 
reliable marker of vitamin D maternal status, 25(OH)D comprises a significant parameter in 
predicting neonatal 25(OH)D3 concentrations, which constitutes the major neonatal vitamin 
D form. The addition of certain maternal parameters could offer additional prognostic value 
in this process, specifically in neonatal 25(OH)D2 concentrations. The additional analytical 
capacity enhances the predictive power with the epimers contributing 11.9% to an overall 
44% explained variances in active vitamin D concentrations in neonates. This result 
significantly exceeded previous reports of 19% in a twin study, which investigated genetic 
versus maternal vitamin D concentrations in determining offspring vitamin D concentrations 
[14]. Overall, the above findings regarding maternal vitamin D concentrations and other 
parameters could be useful in daily clinical practice, as a part of a predictive model for 
neonatal vitamin D concentrations, based on maternal parameters, which could contribute to 
the appropriate management of the major health issue of maternal vitamin deficiency during 
pregnancy. 
Advantages and disadvantages 
The present study has three major advantages. First, the data incorporate specific and 
accurate measurement of seven out of eight forms of vitamin D, including vitamin D2 and D3, 
hydroxylated derivatives and epimer forms. To the best of our knowledge, these data are 
unique to the literature on pregnancy. Second, as routine assays do not allow differentiation 
among the full range of different vitamin D forms, this novel assay allowed for a very 
detailed approach to the complex vitamin D metabolism in the mother - newborn bipole. 
Third, the study allowed the control for maternal characteristics such as age, UVB exposure, 
dietary intake and PTH, Ca and P concentrations, which afforded separating the explained 
variances for the active vitamin D concentrations over and above the shared variances by 
maternal characteristics. In combination, we were able to explain 56.1% in the variances in 
neonatal 25(OH)D concentrations. Limitations of the study were its rather small sample size 
and its cross-sectional design, which prevented prospective data to be collected throughout 
pregnancy. Moreover, measurement of vitamin D-binding protein (VDBP), a significant 
parameter of vitamin D dynamics in pregnancy, was not feasible. 
Conclusions 
This study provided evidence for i) maternal and neonatal vitamin 25(OH)D concentrations 
in a sunny European area, which proved to be sub-optimal, ii) 3-epi-25(OH)D3 and 3-epi-
25(OH)D2 forms in both mothers and neonates, which contribute approximately 25% to the 
total vitamin D concentrations and iii) a relationship between maternal and neonatal 
concentrations leading to a prediction model. The accurate assay highlights a considerable 
proportion of vitamin D exists as epimers and there is a lack of correlation between the 
circulating and active forms. These results underscore the need for accurate measurements to 
appraise vitamin D status. The results, based on specific and accurate measurement, revealed 
that maternal characteristics and active forms of vitamin D, along with their epimers explain 
56% of neonatal vitamin D concentrations. Further investigation, based on accurate 
measurements of vitamin D metabolites, is warranted to establish optimal concentrations 
during pregnancy, in an attempt to prevent maternal morbidity and developmental 
deficiencies. 
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